Russell Ware is an Oncology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 601 publications with 24,891 citations (h-index 75); ClinicalTrials.gov lists 17 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3333 Burnet Ave
Ml 7015
Cincinnati, OH 452293026
Telephone
513-636-4266Registry record last updated 2 Feb 2015.
Clinical trials
- Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study
Sponsor: Children's Hospital Medical Center, Cincinnati
- Serial Assessment of Fertility Experiences
Sponsor: Children's Hospital Medical Center, Cincinnati
- Full Assessment of Clinical Transfusion Support
Sponsor: Children's Hospital Medical Center, Cincinnati
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Octapharma USA, Inc.Program year20255 payments$10,949openpaymentsdata.cms.gov ↗
- Novo Nordisk Health Care AGProgram year20244 payments$21,319openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20249 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
Cincinnati Childrens Hosp Med Ctr
FY2026$344,224U01HL133883 - Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
Cincinnati Childrens Hosp Med Ctr
FY2025$500,339U01HL133883 - Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
Cincinnati Childrens Hosp Med Ctr
FY2025$282,506U01HL133883
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission
The Lancet Haematology
2023 - Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa
New England Journal of Medicine
2020 - Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa
New England Journal of Medicine
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Rothenberg, MD
Cincinnati Children's Hospital Medical Center
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Stuart Goldstein, MD
Cincinnati Children's Hospital Medical Center
Andrew Redington
Cincinnati Children's Hospital Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”